课题基金 / 基金详情

Self-destructing CRISPR-constructs for targeted genome editing in the retina.

Self-destructing CRISPR-constructs for targeted genome editing in the retina.
用于视网膜靶向基因组编辑的自毁 CRISPR 结构。
批准号:
nhmrc : GNT1123329
负责人:
A/Pr Alex Hewitt
金额:
$67.99万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 --

项目摘要

项目成果

A/Pr Alex Hewitt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite the identification of specific mutations causing many inherited retinal dystrophies, all of these conditions are currently untreatable. We have established gene-editing techniques and have developed a novel mouse model, which will serve as a robust platform for testing different techniques of gene editing in the retina. No other group in the world is known to be using this platform for gene editing and our work will expedite the clinical translation of this technology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translating genetic determinants of glaucoma into better diagnosis and treatment
  • 批准号:
    nhmrc : GNT1150144
  • 项目类别:
    Programs
  • 资助金额:
    $946.6万
  • 财政年份:
    2019
  • 负责人:
    A/Pr Alex Hewitt
  • 依托单位:
Translating genetic determinants of glaucoma into better diagnosis and treatment
  • 批准号:
    nhmrc : 1150144
  • 项目类别:
    Program Grants
  • 资助金额:
    $631.19万
  • 财政年份:
    2019
  • 负责人:
    A/Pr Alex Hewitt
  • 依托单位:
Translation of glaucoma blindness genes to improve clinical practice
  • 批准号:
    nhmrc : 1147571
  • 项目类别:
    Project Grants
  • 资助金额:
    $57.13万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Alex Hewitt
  • 依托单位:
Translation of glaucoma blindness genes to improve clinical practice
  • 批准号:
    nhmrc : GNT1147571
  • 项目类别:
    Project Grants
  • 资助金额:
    $84.5万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Alex Hewitt
  • 依托单位:
海外基金